| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
| Sales | 261 | 478 | 4,002 | 2,357 | 979 |
| Sales Growth | -45.50% | -88.05% | +69.80% | +140.65% | unch |
| Net Income | -7,409 | -5,807 | -10,347 | -8,780 | -7,716 |
| Net Income Growth | -27.58% | +43.87% | -17.86% | -13.78% | unch |
Promino Nutritional Sciences Inc. (MUSL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Promino Nutritional Sciences Inc is a nutraceutical company specializing in the development of patented and science-based products for the consumer packaged goods market, with a portfolio focused specifically on muscle health. Promino's product, Rejuvenate, is a patented proprietary formula that assists in the building, rebuilding, restoration, and rejuvenation of natural muscle mass. Promino also offers Promino, a performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength, and accelerate recovery from injury.
Fiscal Year End Date: 12/31